Bayer announced regarding discontinuing supply of 'Kogenate FS' that they can supply the drug constantly to 20 patients
According to the Korea Hemophilia Association, on July 1, Bayer announced regarding discontinuing supply of 'Kogenate FS' that they can supply the drug constantly to 20 patients, and continue supplying Kogenate FS to patients for whom it is difficult to substitute with alternative drug. However, ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
